Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Drew A. LaBreck
Observed names:
Drew A LaBreck,
Drew LaBreck,
Labreck, Drew A
Institutions:
University of Oklahoma Health Sciences Center,
University of Oklahoma
Observed institutions:
University of Iowa,
University of Oklahoma Health Sciences Center,
University of Nebraska Medical Center,
University of Oklahoma
ORCID:
0009-0001-3416-0323
Observed ORCID:
0009-0001-3416-0323
OpenAlex ID:
A5042645455
The MUC1–HIF-1α signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling
2024
·
Divya Murthy
, Kuldeep S. Attri
, et al.
·
Proceedings of the National Academy of Sciences
·
54
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
2023
·
Nicholas J. Mullen
, Surendra K. Shukla
, et al.
·
eLife
·
54
KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
·
Cancer Research
·
8
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
2024
·
Nicholas J. Mullen
, Surendra K. Shukla
, et al.
·
eLife
·
4
DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
2023
·
Nicholas J. Mullen
, Surendra K. Shukla
, et al.
·
eLife
·
1
PDF
KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer.
2026
·
Singh, Pankaj K
, Hu, Tuo
, et al.
·
UNC Libraries
Supplementary Figure S7 from KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
Supplementary Figure S2 from KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
Supplementary Figure S10 from KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
Supplementary Figure S3 from KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
Supplementary Figure S1 from KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
Supplementary Figure S8 from KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
Supplementary Figure S4 from KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
Supplementary Figure S9 from KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
Data from KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
Supplementary Figure S6 from KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
Supplementary Figure S5 from KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
Supplementary Table S1 from KRAS Signaling Inhibition Induces a Targetable Metabolic Dependency on Lipophagy-Dependent Fatty Acid Oxidation in Pancreatic Cancer
2026
·
Ravi Thakur
, Dezhen Wang
, et al.
Author response: DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
2024
·
Nicholas J Mullen
, Surendra K Shukla
, et al.
·
eLife
Author Response: DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
2024
·
Nicholas J. Mullen
, Surendra K. Shukla
, et al.
·
eLife
PDF
Show more works
View as search
Works count:
20
Citation count:
121
H-index:
4
I10-index:
2
Year
Topic
Type